drugset / Trial / NCT01501890

Progesterone for First Trimester Vaginal Bleeding

NCT01501890 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnancy outcomes.

Timeline

Start
2012-01
Primary completion
2013-12
Completion
2014-09

Outcome

Outcome not reported

Stopped: “never started”

Drugs

EvaluationDrugModalityDoseRoute
Comparator dihydroxyprogesterone caproate Unknown 250 mg Intramuscular